People 50 or older are at over 6 times greater risk of getting pneumococcal pneumonia.*
When it comes to pneumococcal disease, feeling healthy isn’t enough.
Over time, your immune system naturally ages. And as it ages, it weakens. This makes it harder for your body to defend against potentially serious illnesses like pneumococcal pneumonia and invasive pneumococcal disease.
People 50 or older are at over 6 times greater risk of getting pneumococcal pneumonia.*
*Compared with adults 18 to 49.
If you’ve had pneumococcal pneumonia before, that doesn’t mean you’re in the clear.
Even if you’ve had it in the past, you may still be at risk of getting it again. With one dose of Prevnar 20®, eligible adults can get lasting protection† against 20 strains of the bacteria that cause pneumococcal pneumonia and invasive pneumococcal disease.
†Based on a clinical study for Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) showing protection for approximately 4 years. Prevnar 20 and Prevnar 13 are manufactured and formulated similarly and contain 13 of the same polysaccharide conjugates.
Having certain chronic conditions may further increase your risk.
See how your health conditions may affect your risk for pneumococcal pneumonia.
https://main--aemadultprevnar20com--pfizer.hlx.page/global/fragments/ageandrisk-chart
One vaccine. One dose. One visit.
Prevnar 20 was designed to help protect adults from 20 strains of the bacteria that cause both pneumococcal pneumonia and invasive pneumococcal disease. Prevnar 20 is a one-time dose.
If you've already been vaccinated with another pneumococcal vaccine like PCV13 or PCV15, ask your doctor or pharmacist if you are eligible for Prevnar 20.
PCV13=13-valent pneumococcal conjugate vaccine; PCV15=15-valent pneumococcal conjugate vaccine.